148 related articles for article (PubMed ID: 18930004)
1. Lactic acid bacteria-enclosing poly(epsilon-caprolactone) microcapsules as soil bioamendment.
Takei T; Yoshida M; Hatate Y; Shiomori K; Kiyoyama S
J Biosci Bioeng; 2008 Sep; 106(3):268-72. PubMed ID: 18930004
[TBL] [Abstract][Full Text] [Related]
2. Release behaviors of porous poly(butylene succinate)/poly(epsilon-caprolactone) microcapsules containing indomethacin.
Park SJ; Lee YM; Hong SK
Colloids Surf B Biointerfaces; 2006 Feb; 47(2):211-5. PubMed ID: 16413177
[TBL] [Abstract][Full Text] [Related]
3. Microencapsulation using poly(L-lactic acid). I: Microcapsule properties affected by the preparative technique.
Jalil R; Nixon JR
J Microencapsul; 1989; 6(4):473-84. PubMed ID: 2585239
[TBL] [Abstract][Full Text] [Related]
4. Effect of acid-base interaction between silica and fragrant oil in the PCL/PEG microcapsules.
Park SJ; Yang YJ; Lee HB
Colloids Surf B Biointerfaces; 2004 Oct; 38(1-2):35-40. PubMed ID: 15465302
[TBL] [Abstract][Full Text] [Related]
5. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
[TBL] [Abstract][Full Text] [Related]
6. Determination of poly(epsilon-caprolactone) solubility parameters: application to solvent substitution in a microencapsulation process.
Bordes C; Fréville V; Ruffin E; Marote P; Gauvrit JY; Briançon S; Lantéri P
Int J Pharm; 2010 Jan; 383(1-2):236-43. PubMed ID: 19781605
[TBL] [Abstract][Full Text] [Related]
7. Poly (epsilon-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics.
Karataş A; Sonakin O; Kiliçarslan M; Baykara T
J Microencapsul; 2009 Feb; 26(1):63-74. PubMed ID: 18608798
[TBL] [Abstract][Full Text] [Related]
8. Polymers for biodegradable medical devices. X. Microencapsulation studies: control of poly-hydroxybutyrate-hydroxyvalerate microcapsules porosity via polycaprolactone blending.
Embleton JK; Tighe BJ
J Microencapsul; 1993; 10(3):341-52. PubMed ID: 8377092
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two types of alginate microcapsules on stability and biocompatibility in vitro and in vivo.
Li HB; Jiang H; Wang CY; Duan CM; Ye Y; Su XP; Kong QX; Wu JF; Guo XM
Biomed Mater; 2006 Mar; 1(1):42-7. PubMed ID: 18458385
[TBL] [Abstract][Full Text] [Related]
10. Effect of oxygen plasma treatment on the release behaviors of poly(epsilon-caprolactone) microcapsules containing tocopherol.
Park SJ; Kim KS
Colloids Surf B Biointerfaces; 2005 Jul; 43(3-4):138-42. PubMed ID: 15936181
[TBL] [Abstract][Full Text] [Related]
11. Reservoir-type microcapsules prepared by the solvent exchange method: effect of formulation parameters on microencapsulation of lysozyme.
Park JH; Ye M; Yeo Y; Lee WK; Paul C; Park K
Mol Pharm; 2006; 3(2):135-43. PubMed ID: 16579642
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of PEO-PCL-PEO triblock copolymers: effects of the PCL chain length on the physical property of W(1)/O/W(2) multiple emulsions.
Cho HK; Cho KS; Cho JH; Choi SW; Kim JH; Cheong IW
Colloids Surf B Biointerfaces; 2008 Aug; 65(1):61-8. PubMed ID: 18400473
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase inhibitor loaded PCL microspheres prepared by S/O/W technique using ethanol as pretreatment agent.
Zhang Y; Zhang Y; Guo S; Huang W
Int J Pharm; 2009 Mar; 369(1-2):19-23. PubMed ID: 19041382
[TBL] [Abstract][Full Text] [Related]
14. Synergy of two thermophiles enables decomposition of poly-epsilon-caprolactone under composting conditions.
Nakasaki K; Matsuura H; Tanaka H; Sakai T
FEMS Microbiol Ecol; 2006 Dec; 58(3):373-83. PubMed ID: 17117982
[TBL] [Abstract][Full Text] [Related]
15. A biodegradable, immunoprotective, dual nanoporous capsule for cell-based therapies.
Zhang X; He H; Yen C; Ho W; Lee LJ
Biomaterials; 2008 Nov; 29(31):4253-9. PubMed ID: 18694595
[TBL] [Abstract][Full Text] [Related]
16. K562 cell growth activity and metabolism characteristics in APA microencapsulated culture and modeling study.
Ma J; Qi W; Xie Y; Wang W; Yu W; Ma X
J Biotechnol; 2006 Sep; 125(2):242-51. PubMed ID: 16621095
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of poly(styrene) microcapsules containing corrosion inhibitors.
Mac A; Negi D; Friend D
J Microencapsul; 1989; 6(3):361-7. PubMed ID: 2760783
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable polymer microcapsules fabrication through a template-free approach.
Yu X; Zhao Z; Nie W; Deng R; Liu S; Liang R; Zhu J; Ji X
Langmuir; 2011 Aug; 27(16):10265-73. PubMed ID: 21766809
[TBL] [Abstract][Full Text] [Related]
19. Production of cell-enclosing hollow-core agarose microcapsules via jetting in water-immiscible liquid paraffin and formation of embryoid body-like spherical tissues from mouse ES cells enclosed within these microcapsules.
Sakai S; Hashimoto I; Kawakami K
Biotechnol Bioeng; 2008 Jan; 99(1):235-43. PubMed ID: 17705234
[TBL] [Abstract][Full Text] [Related]
20. The resistance of polyvinylpyrrolidone-iodine-poly(-caprolactone) blends to adherence of Escherichia coli.
Jones DS; Djokic J; Gorman SP
Biomaterials; 2005 May; 26(14):2013-20. PubMed ID: 15576175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
